Alder BioPharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ALDR and buy or sell other stocks, ETFs, and their options commission-free!About ALDR
Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine.
CEOThomas Ripp
CEOThomas Ripp
Employees—
Employees—
HeadquartersBothell, Washington
HeadquartersBothell, Washington
Founded2004
Founded2004
Employees—
Employees—
ALDR Key Statistics
Market cap1.58B
Market cap1.58B
Price-Earnings ratio-4.24
Price-Earnings ratio-4.24
Dividend yield—
Dividend yield—
Average volume5.30M
Average volume5.30M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$19.12
52 Week high$19.12
52 Week low$8.39
52 Week low$8.39
Stock Snapshot
The current Alder BioPharmaceuticals(ALDR) stock price is $18.88, with a market capitalization of 1.58B. The stock trades at a price-to-earnings (P/E) ratio of -4.24.
Alder BioPharmaceuticals(ALDR) stock opened on 2025-12-14 at —. The price climbed to — and dipped to —.
Alder BioPharmaceuticals(ALDR) shares are trading with a volume of 0, against a daily average of 5.3M.
In the last year, Alder BioPharmaceuticals(ALDR) shares hit a 52-week high of $19.12 and a 52-week low of $8.39.
In the last year, Alder BioPharmaceuticals(ALDR) shares hit a 52-week high of $19.12 and a 52-week low of $8.39.